Epidermolysis Bullosa (EB) World Congress 2020
19-23 January 2020, Mölnlycke will attend the 1st meeting of the Epidermolysis Bullosa (EB) World Congress in London. For 30 years, we have been driven by our commitment to reducing patient suffering. We are taking this commitment into the future – let’s continue to minimise pain, together. Come to our booth and tell us about your everyday life treating patients with EB.
EB World Congress
Park Plaza London Riverbank Hotel
19-23 January 2020
To read more and register: https://ebworldcongress.org/register/
It starts with listening
We believe that listening to healthcare professionals, as well as patients, is invaluable for medical advancement. The insights of patients, families and healthcare professionals create a foundation for new technologies and practices.
Our purpose is to advance the performance of healthcare professionals around the world. In order to do that, we need to understand their needs and requirements, and openly share knowledge. It’s only then that we can create solutions that are right for care givers and their patients.
We want to make lives better
In the mid-1980s, the young product developer Tomas Fabo noticed how many patients suffered during dressing changes. It broke his heart to see people scream and cry, and children sometimes having to be sedated – because of the pain at dressing changes.
Fabo worked at Mölnlycke® Wound Care division and his observations led to the development of a siliconebased adhesive which would later be known as Safetac®. The idea was simple; if the dressing doesn’t stick to the wound or damage skin, pain at removal will be reduced.
The lesson from this development was an important one. It tells the story of how a small, passionate team of researchers can have a positive impact on the lives of millions of people through direct observation and a determination to do things differently.